These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3414260)

  • 41. Polypharmacy in psychiatry: a multi-state comparison of psychotropic drug combinations.
    Sheppard C; Beyel V; Fracchia J; Merlis S
    Dis Nerv Syst; 1974 Apr; 35(4):183-9. PubMed ID: 17894114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of treatment with an amino oxidase inhibitor on the excretion of bufotenin and the clinical symptoms in chronic schizophrenic patients.
    Heller B
    Int J Neuropsychiatry; 1966 Apr; 2(2):193-203. PubMed ID: 5959966
    [No Abstract]   [Full Text] [Related]  

  • 43. [The factors influencing the effectiveness of therapy in schizophrenia and the principles of patient selection for a comparative evaluation of the results of treatment (a survey of the literature)].
    Karimov RK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):612-9. PubMed ID: 4574524
    [No Abstract]   [Full Text] [Related]  

  • 44. [The dynamics of blood serum middle-molecule peptides in the prognosis of the course of acute pancreatitis].
    Ivanov PA; Grishin AV; Syromiatnikova ED; Golikov PP; Shcherbiuk AN; El'kov AN
    Vestn Khir Im I I Grek; 1999; 158(6):32-5. PubMed ID: 10709267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [On the problem of the general and elective action of psycholeptics in the therapy of schizophrenia].
    Smulevich AB; Golovan' LI; Sokolova ED; Tsutsul'kovskaia MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(2):246-50. PubMed ID: 5655743
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of thioridazine and fluphenazine on the pituitary, thyroid and adrenal functions in patients with paranoid schizophrenia.
    Horodnicki JM; Czekalski S; Jarema M
    Psychiatr Pol; 1984; 18(3):205-11. PubMed ID: 6536002
    [No Abstract]   [Full Text] [Related]  

  • 47. [Level of peptides in blood serum in experimental traumatic illness].
    Safarian ZS; Piloian AG; Oganisian AI; Akopian TN
    Vopr Med Khim; 1993; 39(6):40-2. PubMed ID: 8303872
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug management in chronic schizophrenia.
    Tune LE; McHugh PR; Coyle JT
    Johns Hopkins Med J; 1982 Jan; 150(1):45-8. PubMed ID: 7054584
    [No Abstract]   [Full Text] [Related]  

  • 49. [Comparative study of trifluperidol and trifluoperazine in the treatment of acute schizophrenia].
    Gauthier R; Hillel J; Bordeleau JM; Tétreault L
    Union Med Can; 1967 Aug; 96(8):936-43. PubMed ID: 5618135
    [No Abstract]   [Full Text] [Related]  

  • 50. [Natural evolution of paranoid schizophrenia treated consecutively with 4 different neuroleptics].
    Portier A; Sarfati Y
    Encephale; 2000; 26(4):75-7. PubMed ID: 11064844
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intermediate molecular weight substances in sera of psoriatic patients.
    Felmérai I; Gróf J; Idei M; Menyhárt J
    Acta Physiol Acad Sci Hung; 1982; 60(3):135-8. PubMed ID: 7185254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Language regression to the mother tongue in polyglot patients with acute psychosis].
    Heinemann F; Assion HJ
    Nervenarzt; 1996 Jul; 67(7):599-601. PubMed ID: 8927199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Middle molecular weight peptides from rat blood serum during acute liver injury and administration of iodinated oil].
    Turianitsa IM; Rostoka LM; Fedorovich TM; Turianitsa SM
    Ukr Biokhim Zh (1978); 1991; 63(2):102-5. PubMed ID: 1882452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Oxyhemometric studies of patients with schizophrenia and reactive psychoses while treating them with neuroleptics].
    Timofeev NN; Kondrashenko VT; Nemtseva NIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(6):906-13. PubMed ID: 5723252
    [No Abstract]   [Full Text] [Related]  

  • 55. [Immunologic study of serum protein fractions in paranoid forms of schizophrenia].
    Abaskuliev AA; Rzaev NA; Ismailov NV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(12):1832-7. PubMed ID: 4661024
    [No Abstract]   [Full Text] [Related]  

  • 56. Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology.
    Rothermundt M; Missler U; Arolt V; Peters M; Leadbeater J; Wiesmann M; Rudolf S; Wandinger KP; Kirchner H
    Mol Psychiatry; 2001 Jul; 6(4):445-9. PubMed ID: 11443531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pergolide as adjuvant therapy to amisulpride in the treatment of negative and depressive symptoms in schizophrenia.
    Roesch-Ely D; Göhring K; Gruschka P; Kaiser S; Pfüller U; Burlon M; Weisbrod M
    Pharmacopsychiatry; 2006 May; 39(3):115-6. PubMed ID: 16721703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The role of middle-molecule peptides in the pathogenesis of traumatic disease].
    Nemchenko NS; Belozerova LA; Eriukhin IA; Shanin VIu; Cherniakov GM
    Vestn Khir Im I I Grek; 1994; 153(7-12):65-9. PubMed ID: 7625041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Blood level of tryptophan in psychiatric diseases].
    Zarifian E
    Encephale; 1976; 2(3):211-3. PubMed ID: 991801
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative survey of psychiatrists' prescription preferences: New York and Texas.
    Sheppard C; Beyel V; Moan E; Fracchia J; Merlis S
    South Med J; 1975 Jul; 68(7):876-80. PubMed ID: 1154075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.